Gene disruption methodologies for drug target discovery

Details for Australian Patent Application No. 2002231144 (hide)

Owner ELITRA PHARMACEUTICALS, INC.

Inventors Jiang, Bo; Boone, Charles; Roemer, Terry; Ohlsen, Kari L.; Bussey, Howard

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2002231144

PCT Pub. Number WO2002/053728

Priority 60/259,128 29.12.00 US; 09/792,024 20.02.01 US; 60/314,050 22.08.01 US

Filing date 26 December 2001

Wipo publication date 16 July 2002

International Classifications

C12N 015/00 Mutation or genetic engineering

Event Publications

23 January 2003 Application Open to Public Inspection

  Published as AU-A-2002231144

27 January 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002231145-360degrees rotational directional nozzle for trigger sprayers

2002231143